Head Neck

• 

  Publication Venue For

  • Head and neck cancer research collaborations between the United States and low- and middle-income countries: 10-year publication analysis..  43:2395-2404. 2021
  • Survival outcomes for head and neck patients with Medicaid: A health insurance paradox..  43:2136-2147. 2021
  • Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma..  43:1629-1640. 2021
  • Postoperative radiotherapy is associated with improved overall survival for alveolar ridge squamous cell carcinoma with adverse pathologic features..  43:203-211. 2021
  • Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease..  42:2505-2515. 2020
  • Advanced head and neck surgery training during the COVID-19 pandemic..  42:1411-1417. 2020
  • Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma..  41:3056-3063. 2019
  • Salvage laryngectomy and laryngopharyngectomy: Multicenter review of outcomes associated with a reconstructive approach..  41:16-29. 2019
  • Salvage skull base reconstruction in the endoscopic era: Vastus lateralis free tissue transfer..  40:E45-E52. 2018
  • Decreased cancer-independent life expectancy in the head and neck cancer population..  39:1845-1853. 2017
  • ACR appropriateness criteria® nasal cavity and paranasal sinus cancers..  39:407-418. 2017
  • Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma..  39:E15-E19. 2017
  • Prognostic value of midtreatment FDG-PET in oropharyngeal cancer..  38:1472-1478. 2016
  • ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas..  38:1299-1309. 2016
  • ACR Appropriateness criteria® for nasopharyngeal carcinoma..  38:979-986. 2016
  • Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting..  38 Suppl 1:E1826-E1832. 2016
  • ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck..  38:175-182. 2016
  • Primary granulocytic sarcoma of larynx..  37:E38-E44. 2015
  • Comparison of complications in free flap reconstruction for osteoradionecrosis in patients with or without hyperbaric oxygen therapy..  36:1701-1704. 2014
  • Esophageal-subarachnoid fistula: a case of spontaneous tension pneumocephalus in the setting of esophageal cancer..  36:E52-E56. 2014
  • Surgical innovation, industry partnership, and the enemy within..  36:461-465. 2014
  • Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy..  36:215-219. 2014
  • American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer..  36:3-8. 2014
  • Health-related quality of life differences between African Americans and non-Hispanic whites with head and neck cancer..  35:1255-1264. 2013
  • Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers..  35:794-799. 2013
  • Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer..  35:465-466. 2013
  • Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia..  34:1681-1703. 2012
  • Chemoradiation for patients with large-volume laryngeal cancers..  34:1162-1167. 2012
  • Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia..  34:1136-1142. 2012
  • Treatment-induced changes in vocal cord mobility and subsequent local recurrence after organ preservation therapy for laryngeal carcinoma..  34:792-796. 2012
  • ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil..  34:613-616. 2012
  • Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites..  33:847-855. 2011
  • Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk..  33:650-660. 2011
  • Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue..  32:1519-1527. 2010
  • Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids..  32:1209-1216. 2010
  • Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines..  32:700-707. 2010
  • Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma..  32:348-356. 2010
  • Trends in head and neck cancer incidence in Tianjin, China, between 1981 and 2002..  31:175-182. 2009
  • Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy..  30:1535-1542. 2008
  • Venous thromboembolism in patients with head and neck cancer after surgery. 2013